Fibroblast growth factor-2 promotes recovery of pulmonary function in a canine models of elastase-induced emphysema

Experimental Lung Research

Volumn 33, Issue 1, 2007, Pages 15-26

  Morino, Shigeyuki ^a,b,c   Toba, Toshinari ^a   Tao, Hiroyuki ^a   Araki, Masato ^a   Shimizu, Yasuhiko ^a   Nakamura, Tatsuo ^a   Nagayasu, Takeshi ^b   Tagawa, Tsutomu ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Angiogenesis; Bronchoscopic lung volume reduction; Chronic obstructive pulmonary disease (COPD); Fibroblast growth factor 2 (FGF 2); Fibrogenesis

Indexed keywords

ELASTASE; FIBROBLAST GROWTH FACTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; EMPHYSEMA; FEASIBILITY STUDY; LUNG BLOOD FLOW; LUNG FUNCTION; LUNG RESECTION; LUNG VOLUME; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADMINISTRATION, INHALATION; ANIMALS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOGS; EMPHYSEMA; FIBROBLAST GROWTH FACTOR 2; INTUBATION, INTRATRACHEAL; LUNG VOLUME MEASUREMENTS; OXYGEN; PANCREATIC ELASTASE; PNEUMONECTOMY; PULMONARY CIRCULATION; RECOVERY OF FUNCTION; RESPIRATORY FUNCTION TESTS;

EID: 33947242273     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140601113070     Document Type: Article

References (21)

1. Mannino DM: Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care. 2003;48:1185-1191.
2. Cooper JD, Patterson GS, Sundaresan RS, Trulock EP, Yusen RD, Pohl MS, Lefrak SS: Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg. 1996;112:1319-1329.
3. National Emphysema Treatment Trial Research Group: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059-2073.
4. Ingenito EP, Tsai LW, Mentzer SJ, Jaklitsch MT, Reilly JJ, Lutchen K, Mazan M, Hoffman A: Respiratory impedance following bronchoscopic or surgical lung volume reduction for emphysema. Respiration. 2005;72:406-417.
5. Bikfalvi A, Klein S, Pintucci G, Rifkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev. 1997;18:26-45.
6. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Henry E: Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314-322.
7. Doi M, Nakano K, Hiramoto T, Kohno N: Significance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxia. Respir Med. 2003;97:915-920.
8. Morino S, Nakamura T, Toba T, Takahashi M, Kushibiki T, Tabata Y, Shimizu Y: Fibroblast growth factor-2 induces recovery of pulmonary blood flow in canine emphysema models. Chest. 2005;128:920-926.
9. Ingenito EP, Berger RL, Henderson AC, Reilly JJ, Tsai L, Hoffman A: Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med. 2003;167:771-778.
10. Chino K, Choong CK, Toeniskoetter P, Cooper JD: A canine model for production of severe unilateral panacinar emphysema. Exp Lung Res. 2004;30:319-332.
11. Scherle W: A simple method for volumetry of organs in quantitative stereology. Mikroskopie. 1970;26:S57-S60.
12. Gillooly M, Lamb D, Farrow ASJ: New automated technique for assessing emphysema on histological sections. J Clin Pathol. 1991;44:1007-1011.
13. National Emphysema Treatment Trial Research Group: Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med. 2003;348:2092-2102.
14. Drazen JM, Epstein AM: Guidance concerning surgery for emphysema. N Engl J Med. 2003;348:2134-2136.
15. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, Polkey MI: Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005;171:453-460.
16. Venuta F, Giacomo TD, Rendina EA, Ciccone AM, Diso D, Perrone A, Parola D, Anile M, Coloni GF: Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Ann Thorac Surg. 2005;79:411-417.
17. Yim AP, Hwong TM, Lee TW, Li WW, Lam S, Yeung TK, Hui DS, Ko FW, Sihoe AD, Thung KH, Arifi AA: Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg. 2004;127:1564-1573.
18. Lazarous DF, Schinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE, Unger EF: Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
19. Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, Nishimura K, Tabata Y, Komeda M: Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothoracic Surg. 2003;24:105-112.
20. Chabut D, Fischer AM, Colliec-Jouault S, Laurendeau I, Matou S, Bonniec BL, Helley D. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. Mol Pharmacol. 2003;64:696-702.
21. Pepper MS, Vassalli JD, Orci L, Montesano R: Biphasic effect of transforming growth factor beta1 on in vitro angiogenesis. Exp Cell Res. 1993;204:356-363.